Michael Schaffer - Psychemedics VP of Laboratory Operations
VP
Dr. Michael I. Schaffer is Vice President Laboratory Operations of Psychemedics Corporationrationration, since 1999. From 1990 to 1999, he served as Director of Toxicology, Technical Manager and Responsible Person for the Leesburg, Florida laboratory of SmithKline Beecham Clinical Laboratories. From 1976 to 1990 he served as the Chief Toxicologist at the Cook County Medical Examiners office in Chicago, Illinois. From 1990 to 1999, he was also a member of the Board of Directors of the American Board of Forensic Toxicologists. Dr. Schaffer has served as an inspector for the Substance Abuse and Mental Health Services Administrations National Laboratory Certification Program since 1989. Dr. Schaffer has also served as an inspector for the College of American Pathologists since 1990 . since 1999.
| Age | 79 |
| Tenure | 26 years |
| Professional Marks | Ph.D |
| Phone | 800 527 7424 |
| Web | https://www.psychemedics.com |
Michael Schaffer Latest Insider Activity
Tracking and analyzing the buying and selling activities of Michael Schaffer against Psychemedics pink sheet is an integral part of due diligence when investing in Psychemedics. Michael Schaffer insider activity provides valuable insight into whether Psychemedics is net buyers or sellers over its current business cycle. Note, Psychemedics insiders must abide by specific rules, including filing SEC forms every time they buy or sell Psychemedics'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Michael Schaffer over a year ago Payment of 375 shares by Michael Schaffer of Psychemedics subject to Rule 16b-3 | ||
Michael Schaffer over a year ago Payment of 337 shares by Michael Schaffer of Psychemedics subject to Rule 16b-3 |
Psychemedics Management Efficiency
The company has Return on Asset of (0.1624) % which means that on every $100 spent on assets, it lost $0.1624. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.6133) %, meaning that it generated no profit with money invested by stockholders. Psychemedics' management efficiency ratios could be used to measure how well Psychemedics manages its routine affairs as well as how well it operates its assets and liabilities.Psychemedics has 2.3 M in debt with debt to equity (D/E) ratio of 0.36, which is OK given its current industry classification. Psychemedics has a current ratio of 2.02, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Psychemedics until it has trouble settling it off, either with new capital or with free cash flow. So, Psychemedics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Psychemedics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Psychemedics to invest in growth at high rates of return. When we think about Psychemedics' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 4 records | VP Age | ||
| Jason Peterson | Sotera Health Co | N/A | |
| Alexander JD | Sotera Health Co | 66 | |
| Jay PharmD | Castle Biosciences | N/A | |
| Andrew JD | Neuronetics | 51 | |
Management Performance
| Return On Equity | -0.61 | |||
| Return On Asset | -0.16 |
Psychemedics Leadership Team
Elected by the shareholders, the Psychemedics' board of directors comprises two types of representatives: Psychemedics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Psychemedics. The board's role is to monitor Psychemedics' management team and ensure that shareholders' interests are well served. Psychemedics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Psychemedics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Weisenhoff, Principal Manager | ||
| Raymond Kubacki, Chairman, CEO and Pres | ||
| Charles IV, Ex VP | ||
| Shannon Shoemaker, Chief Officer | ||
| Michael Schaffer, VP of Laboratory Operations | ||
| Werner Baumgartner, Founder | ||
| Annette Baumgartner, Founder | ||
| Sarah Ashby, VP Counsel | ||
| Patrick Kinney, Secretary | ||
| Brian Hullinger, CEO President | ||
| Daniella Mehalik, Vice Finance |
Psychemedics Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Psychemedics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.61 | |||
| Return On Asset | -0.16 | |||
| Profit Margin | (0.22) % | |||
| Operating Margin | (0.19) % | |||
| Current Valuation | 14.22 M | |||
| Shares Outstanding | 5.89 M | |||
| Shares Owned By Insiders | 23.14 % | |||
| Shares Owned By Institutions | 20.22 % | |||
| Number Of Shares Shorted | 38.6 K | |||
| Price To Earning | 92.08 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in Psychemedics Pink Sheet
If you are still planning to invest in Psychemedics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Psychemedics' history and understand the potential risks before investing.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |